Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases

Thrombosis Research

Volumn 129, Issue 3, 2012, Pages 267-273

  Maugeri, Norma ^a   Baldini, Mattia ^a   Ramirez, Giuseppe A ^a   Rovere Querini, Patrizia ^a   Manfredi, Angelo A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; AUTOIMMUNE DISEASE; BLEEDING; CELL INTERACTION; CHURG STRAUSS SYNDROME; CRYOGLOBULINEMIA; ENDOTHELIUM CELL; GIANT CELL ARTERITIS; GRANULOMATOSIS; HUMAN; INFLAMMATION; LEUKOCYTE; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NECROSIS; NEGATIVE FEEDBACK; NEUTROPHIL; PATHOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SMALL VESSEL VASCULITIS; THROMBOCYTE; THROMBOSIS; TISSUE INJURY; VASCULAR DISEASE;

ANIMALS; BLOOD PLATELETS; BLOOD VESSELS; CELL COMMUNICATION; HUMANS; NEUTROPHILS; PLATELET ACTIVATION; SIGNAL TRANSDUCTION; VASCULITIS;

EID: 84857793596     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.12.001     Document Type: Review

References (56)

1. L. Totani, and V. Evangelista Platelet-leukocyte interactions in cardiovascular disease and beyond Arterioscler Thromb Vasc Biol 30 2011 2357 2361
2. A.A. Manfredi, P. Rovere-Querini, and N. Maugeri Dangerous connections: neutrophils and the phagocytic clearance of activated platelets Curr Opin Hematol 17 2009 3 8
3. N. Maugeri, M. Baldini, P. Rovere-Querini, A. Maseri, M.G. Sabbadini, and A.A. Manfredi Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity 42 2009 386 388
4. N. Maugeri, S. Malato, and E.A. Femia Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia Blood 118 12 2011 3359 3366
5. N. Maugeri, P. Rovere-Querini, M. Baldini, M.G. Sabbadini, and A.A. Manfredi Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis Clin Exp Immunol 156 2009 395 404
6. N. Maugeri, P. Rovere-Querini, and V. Evangelista Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and ß2 integrin-dependent cell clearance program Blood 113 2009 5254 5265
7. N. Maugeri, P. Rovere-Querini, and M. Slavich Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction J Immunol 187 2011 970 979
8. A.A. Manfredi, and P. Rovere-Querini The mitochondrion-a Trojan horse that kicks off inflammation? N Engl J Med 362 2010 2132 2134
9. N. Maugeri, M. Brambilla, and M. Camera Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation J Thromb Haemost 4 2006 1323 1330
10. A. Hidalgo, J. Chang, J.E. Jang, A.J. Peired, E.Y. Chiang, and P.S. Frenette Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury Nat Med 15 2009 384 391
11. S.R. Clark, A.C. Ma, and S.A. Tavener Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood Nat Med 13 2007 463 469 (Pubitemid 46559832)
12. C. Urban, and A. Zychlinsky Netting bacteria in sepsis Nat Med 13 2007 403 404 (Pubitemid 46559814)
13. A. Mantovani, M.A. Cassatella, C. Costantini, and S. Jaillon Neutrophils in the activation and regulation of innate and adaptive immunity Nat Rev Immunol 11 2011 519 531
14. J.R. Fitzgerald, T.J. Foster, and D. Cox The interaction of bacterial pathogens with platelets Nat Rev Microbiol 4 2006 445 457 (Pubitemid 43771864)
15. J.W. Semple, J.E. Italiano Jr., and J. Freedman Platelets and the immune continuum Nat Rev Immunol 11 2011 264 274
16. A. Rouhiainen, S. Imai, H. Rauvala, and J. Parkkinen Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation Thromb Haemost 84 2000 1087 1094 (Pubitemid 32014046)
17. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu Rev Immunol 29 2011 139 162
18. M.E. Bianchi, and A.A. Manfredi High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity Immunol Rev 220 2007 35 46 (Pubitemid 350045574)
19. C. Fiuza, M. Bustin, and S. Talwar Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652 2660 (Pubitemid 36857626)
20. Baldini M, Maugeri N, Ramirez GA, et al. Selective upregulation of the soluble pattern recognition 1 receptor PTX3 and of VEGF in giant cell arteritis: relevance for recent optic nerve ischemia Arthritis & Rheumatism, 2011 Oct 11. doi: 10.1002/art.33411. [Electronic publication ahead of print].
21. Lin Q, Yang XP, Fang D, et al. High-Mobility Group Box-1 Mediates Toll-Like Receptor 4-Dependent Angiogenesis. Arterioscler Thromb Vasc Biol 2011;31:1024-32.
22. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010;28:367-88.
23. V. Evangelista, Z. Pamuklar, and A. Piccoli Src family kinases mediate neutrophil adhesion to adherent platelets Blood 109 2007 2461 2469 (Pubitemid 46425889)
24. A. Zarbock, H. Muller, Y. Kuwano, and K. Ley PSGL-1-dependent myeloid leukocyte activation J Leukoc Biol 86 2009 1119 1124
25. C. Scheiermann, Y. Kunisaki, J.E. Jang, and P.S. Frenette Neutrophil microdomains: linking heterocellular interactions with vascular injury Curr Opin Hematol 17 2011 25 30
26. S. Jaillon, G. Peri, and Y. Delneste The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps J Exp Med 204 2007 793 804 (Pubitemid 46631609)
27. A.A. Manfredi, P. Rovere-Querini, B. Bottazzi, C. Garlanda, and A. Mantovani Pentraxins, humoral innate immunity and tissue injury Curr Opin Immunol 20 2008 538 544
28. M. Salio, S. Chimenti, and N. De Angelis Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction Circulation 117 2008 1055 1064
29. G.D. Norata, P. Marchesi, and V.K. Pulakazhi Venu Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis Circulation 120 2009 699 708
30. L. Deban, R.C. Russo, and M. Sironi Regulation of leukocyte recruitment by the long pentraxin PTX3 Nat Immunol 11 2010 328 334
31. C.Y. Fung, A.J. Marcus, M.J. Broekman, and M.P. Mahaut-Smith P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window Trends Cardiovasc Med 19 2009 1 5
32. F. Kukulski, F. Bahrami, and F. Ben Yebdri NTPDase1 controls IL-8 production by human neutrophils J Immunol 187 2011 644 653
33. M.C. Hyman, D. Petrovic-Djergovic, and S.H. Visovatti Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39 J Clin Invest 119 2009 1136 1149
34. N. Hu, J. Westra, and C.G. Kallenberg Dysregulated neutrophil-endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention Autoimmun Rev 10 2011 536 543
35. C.O. Savage Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis Clin Exp Immunol 164 Suppl 1 2011 23 26
36. P. Rovere, G. Peri, and F. Fazzini The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells Blood 96 2000 4300 4306
37. A.P. van Rossum, F. Fazzini, and P.C. Limburg The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages Arthritis Rheum 50 2004 2667 2674 (Pubitemid 39062730)
38. F. Fazzini, G. Peri, and A. Doni PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation Arthritis Rheum 44 2001 2841 2850 (Pubitemid 34016204)
39. A.P. van Rossum, H.H. Pas, and F. Fazzini Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis Arthritis Rheum 54 2006 986 991
40. S. Weidner, S. Hafezi-Rachti, and H.D. Rupprecht Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 55 2006 146 149 (Pubitemid 43235140)
41. G. Tomasson, M. Lavalley, and K. Tanriverdi Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis J Rheumatol 38 2011 1048 1054
42. A. Castiglioni, V. Canti, P. Rovere-Querini, and A.A. Manfredi High-mobility group box 1 (HMGB1) as a master regulator of innate immunity Cell Tissue Res 343 2011 189 199
43. V.V. Orlova, E.Y. Choi, and C. Xie A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin EMBO J 26 2007 1129 1139
44. A. Bruchfeld, M. Wendt, and J. Bratt High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations Mol Med 17 2011 29 35
45. Henes FO, Chen Y, Bley TA, et al. Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's). Ann Rheum Dis 2011;70:1926-9.
46. D. Wibisono, E. Csernok, P. Lamprecht, J.U. Holle, W.L. Gross, and F. Moosig Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis Ann Rheum Dis 69 2011 1888 1889
47. A.L. Bergstrom, B.A. Bengtsson, L.B. Olsson, B.E. Malmvall, and J. Kutti Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy Ann Rheum Dis 38 1979 244 247 (Pubitemid 9236374)
48. N.S. Lincoff, P.D. Erlich, and L.S. Brass Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis J Neuroophthalmol 20 2000 67 72 (Pubitemid 30399029)
49. R. Foroozan, H. Danesh-Meyer, P.J. Savino, G. Gamble, O.N. Mekari-Sabbagh, and R.C. Sergott Thrombocytosis in patients with biopsy-proven giant cell arteritis Ophthalmology 109 2002 1267 1271 (Pubitemid 34700916)
50. G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow, and M. Sonnenblick Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis Rheum 50 2004 1332 1337 (Pubitemid 38480844)
51. G. Nesher, Y. Berkun, and M. Mates Risk factors for cranial ischemic complications in giant cell arteritis Medicine (Baltimore) 83 2004 114 122 (Pubitemid 38524628)
52. C. Garcia-Porrua, R. Santamarina, V. Armesto, and M.A. Gonzalez-Gay Magnetic resonance imaging in optic neuritis due to giant cell arteritis Arthritis Rheum 53 2005 313 314 (Pubitemid 40530177)
53. C.T. Berger, M. Wolbers, P. Meyer, T. Daikeler, and C. Hess High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition Rheumatology (Oxford) 48 2009 258 261
54. G. Di Comite, P. Previtali, and C.M. Rossi High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment Ann Rheum Dis 68 2009 293 295
55. T. Ishihara, G. Haraguchi, T. Kamiishi, D. Tezuka, H. Inagaki, and M. Isobe Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker J Am Coll Cardiol 57 2011 1712 1713
56. L. Dagna, F. Salvo, and M. Tiraboschi Pentraxin-3 as a marker of disease activity in Takayasu's arteritis Ann Intern Med 155 7 2011 425 433